Build status - In Progress

T-Cell Response to Vaccination

Study on Immune Response to Vaccination

T-Cell Response to Vaccination
Recruiting
18 years - 100 years
All
Phase N/A
1 Location

Brief description of study

The purpose of this study is to see how your body forms a protective response after vaccination and how it deals with viral variants. We are studying the immune response to the COVID-19 vaccines. 

Detailed description of study

The study consists of a screening visit followed by other study visits. From the time of screening, you will be in this study for around 9 months.
 
You may be eligible if you plan to receive the vaccine (initial or booster) but have not yet gotten it yet. 
 
The COVID-19 vaccination study includes: a screening visit (approx 1 hour) to check your eligibility. If you qualify, you will come in for the following study visits: Study Visit 1 - Pre-Donor Evaluation (30 min) and Leukopheresis (approx 2.5-4 hours), Visit 2 – vaccination at your place of choice. The study team will not be providing the vaccine. Study Visits 3 - 8 - Blood Draws (approx 30 mins), Study Visit 9 - Leukopheresis (approx 2.5-4 hours). 
 
 
There are additional optional procedures that you may choose to participate in. These include fine needle aspiration (FNA) of the lymph nodes under your armpit to see how protective antibodies are being generated. You may also choose to participate in periodic blood draws/leukopheresis to see how immune protection holds up over the long-term.
 

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: healthy Volunteers,healthy subjects,Healthy,Healthy volunteer,healthy,healthy volunteer,healthy volunteers,healthy subjects,COVID-19,coronavirus,covid,vaccine,vaccination,covid-19,covid-19 vaccinations
  • Age: 18 years - 100 years
  • Gender: All

Must be receiving a COVID-19 vaccines or booster

Must be willing to consent to blood draws 

This study investigates how the body forms a protective response after receiving a COVID-19 vaccine. The purpose is to understand how the immune system reacts to the vaccine and deals with different viral variants.

The study focuses on evaluating the immune response in people who are about to receive a COVID-19 vaccine or booster. It aims to gather information about the safety and effectiveness of the vaccine in generating a protective immune response.

  • Who can participate: Participants must be planning to receive a COVID-19 vaccine or booster and be willing to consent to blood draws.
  • Study details: Participants will engage in activities including blood draws. The study does not provide the vaccine itself.
  • Study timelines and visits: The study will last around 9 months. The study requires 9 visits.
Updated on 04 Aug 2024. Study ID: 820884

Pre-Screener

Check if you are eligible Enter contact details Select a study center Select best time to contact

Are you 18 years of age or older?

Preview complete

The prescreener preview is complete. You may now close the preview.

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center